Q/C TECHNOLOGIES INC (QCLS) Stock Price, Forecast & Analysis
USA - NASDAQ:QCLS - US62856X2018 - Common Stock
QCLS Key Statistics, Chart & Performance
The current stock price of QCLS is 3 USD. In the past month the price decreased by -18.48%.
QCLS Latest News, Press Relases and Analysis
QCLS Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 42.04 | 874.88B | ||
| JNJ | JOHNSON & JOHNSON | 17.97 | 449.32B | ||
| MRK | MERCK & CO. INC. | 9.79 | 215.51B | ||
| PFE | PFIZER INC | 7.63 | 138.90B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 7.12 | 95.03B | ||
| ZTS | ZOETIS INC | 18.97 | 53.29B | ||
| RPRX | ROYALTY PHARMA PLC- CL A | 9.38 | 22.49B | ||
| VTRS | VIATRIS INC | 4.34 | 11.80B | ||
| ELAN | ELANCO ANIMAL HEALTH INC | 22.39 | 10.68B | ||
| CORT | CORCEPT THERAPEUTICS INC | 83.77 | 7.77B | ||
| AXSM | AXSOME THERAPEUTICS INC | N/A | 6.89B | ||
| CRNX | CRINETICS PHARMACEUTICALS IN | N/A | 3.77B |
Related stock screener links
About QCLS
Company Profile
Q/C Technologies, Inc. operates as a clinical-stage pharmaceutical company, which engages in the development of drug products to extend healthy lifespan. The company is headquartered in New York City, New York and currently employs 2 full-time employees. The company went IPO on 2008-07-24. The Company, through a licensing agreement with LightSolver, holds rights to the use of quantum-inspired laser-based processing units (LPUs) that solve compute-intensive combinatorial and physical problems at the speed of light. The firm bridges a disruptive computing paradigm for high-speed photonic computing with cryptocurrency infrastructure development at scale, enabling performance and sustainability for blockchain applications. Lightsolver’s architecture is designed to improve security for blockchain operations for the cryptocurrency industry.
Company Info
Q/C TECHNOLOGIES INC
1185 Avenue Of The Americas, Suite 249
New York City NEW YORK US
Employees: 2
Phone: 18568488698
Q/C TECHNOLOGIES INC / QCLS FAQ
What does QCLS do?
Q/C Technologies, Inc. operates as a clinical-stage pharmaceutical company, which engages in the development of drug products to extend healthy lifespan. The company is headquartered in New York City, New York and currently employs 2 full-time employees. The company went IPO on 2008-07-24. The Company, through a licensing agreement with LightSolver, holds rights to the use of quantum-inspired laser-based processing units (LPUs) that solve compute-intensive combinatorial and physical problems at the speed of light. The firm bridges a disruptive computing paradigm for high-speed photonic computing with cryptocurrency infrastructure development at scale, enabling performance and sustainability for blockchain applications. Lightsolver’s architecture is designed to improve security for blockchain operations for the cryptocurrency industry.
What is the stock price of Q/C TECHNOLOGIES INC today?
The current stock price of QCLS is 3 USD. The price increased by 7.53% in the last trading session.
Does QCLS stock pay dividends?
QCLS does not pay a dividend.
What is the ChartMill technical and fundamental rating of QCLS stock?
QCLS has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
Should I buy QCLS stock?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on QCLS.
What is the market capitalization of QCLS stock?
Q/C TECHNOLOGIES INC (QCLS) has a market capitalization of 5.55M USD. This makes QCLS a Nano Cap stock.
Can you provide the short interest for QCLS stock?
The outstanding short interest for Q/C TECHNOLOGIES INC (QCLS) is 26.12% of its float.
QCLS Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to QCLS.
QCLS Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to QCLS. While QCLS seems to be doing ok healthwise, there are quite some concerns on its profitability.
QCLS Financial Highlights
Over the last trailing twelve months QCLS reported a non-GAAP Earnings per Share(EPS) of -56.09. The EPS decreased by -449.92% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -61.38% | ||
| ROE | -90.74% | ||
| Debt/Equity | 0 |